Compare IDEXX Laboratories, Inc. (IDXX) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs State Street PDR S&P Retail ETF — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while State Street PDR S&P Retail ETF trades at $84.09 (market cap $389.66M). The key difference: IDEXX Laboratories, Inc. is far larger — about 103.8× State Street PDR S&P Retail ETF's market cap, and State Street PDR S&P Retail ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and State Street PDR S&P Retail ETF for 45 Days on average.
| IDXX | XRT | |
|---|---|---|
Market Cap | $40.43B | $389.66M |
Volume | 692,164 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $766.68 | $92.35 |
52-Week Low | $504.70 | $77.28 |
Typical Hold Time | 46 Days | 45 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
XRT, the SPDR S&P Retail ETF, trades at $83.91, up 1.21% on the day. The technical outlook is mixed with a bullish overall signal but bearish moving averages and an overbought RSI_6 at 84.45. Recent retail sales data shows volatility, with August rebounding 1.2% after a July decline. The ETF's fundamentals are not detailed in the snapshot, but it tracks the retail sector, facing headwinds from inflation and interest rates.
The outlook for XRT is cautious. While holiday sales projections exceed $1 trillion, macroeconomic pressures and analyst skepticism suggest potential underperformance. Key risks include consumer sentiment shifts and oil price volatility. Investors should weigh sector exposure against broader market alternatives like IVV.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
